AI-generated summary
The authors randomized 31 patients with chronic rhinosinusitis to photobiomodulation therapy or a sham laser control, with 12 sessions over treatment. They report that the therapy group showed significant improvement in headache, fatigue, and sinus opacification compared with controls.
- Participants
- 31
- Who or what was studied
- Patients with chronic rhinosinusitis
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The abstract describes a relatively small sample of 31 patients and does not report a longer-term follow-up period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
- Total energy
- 2.5 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Control group, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.